Large-cap Health Care company Eli Lilly and has logged a 0.2% change today on a trading volume of 687,646. The average volume for the stock is 3,800,773.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. Based in Indianapolis, United States the company has 47,000 full time employees and a market cap of $943,189,065,728. Eli Lilly and currently offers its equity investors a dividend that yields 0.6% per year.
The company is now trading 3.95% away from its average analyst target price of $1012.19 per share. The 27 analysts following the stock have set target prices ranging from $770.0 to $1500.0, and on average give Eli Lilly and a rating of buy.
Over the last 52 weeks, LLY stock has risen 40.0%, which amounts to a 28.3% difference compared to the S&P 500. The stock's 52 week high is $1057.0 whereas its 52 week low is $623.78 per share. With its net margins declining an average -7.3% over the last 6 years, Eli Lilly and may not have a strong enough profitability trend to support its stock price.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 45,042,700 | 10,590,000 | 24 | 60.0 |
| 2023 | 34,124,100 | 5,240,400 | 15 | -31.82 |
| 2022 | 28,541,400 | 6,244,800 | 22 | 10.0 |
| 2021 | 28,318,400 | 5,581,700 | 20 | -20.0 |
| 2020 | 24,539,800 | 6,193,700 | 25 | -32.43 |
| 2019 | 22,319,500 | 8,318,400 | 37 |
